Funds › Virtus Investment Advisers, LLC
Virtus Investment Advisers, LLC
13F for Q3 2026, filed Nov 12, 2026. 458 positions worth $452.8M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Latest report
Q3 2026
filed Nov 12, 2026
Reported value
$452.8M
+$23.6M (5.5%) vs Q2 2026
Positions
458
463 in Q2 2026
Top 10 share
9.5%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Virtus Investment Advisers, LLC in the latest 13F quarter?
Using 13F.ai, how has Virtus Investment Advisers, LLC's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Virtus Investment Advisers, LLC's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | MRNA Moderna, Inc. | 33,770 | $6.5M | 1.4% | +44.9% | 13F ↗ |
| 2 | IOVA Iovance Biotherapeutics, Inc. | 413,111 | $6.1M | 1.4% | +44.9% | 13F ↗ |
| 3 | REGN Regeneron Pharmaceuticals, Inc. | 5,490 | $4.2M | 0.9% | +27.1% | 13F ↗ |
| 4 | GILD Gilead Sciences, Inc. | 27,587 | $4.1M | 0.9% | +18.1% | 13F ↗ |
| 5 | AMGN Amgen Inc. | 9,586 | $4.0M | 0.9% | +11.8% | 13F ↗ |
| 6 | VRTX Vertex Pharmaceuticals Incorporated | 7,668 | $4.0M | 0.9% | +193% | 13F ↗ |
| 7 | OMER Omeros Corporation | 192,959 | $3.7M | 0.8% | +44.9% | 13F ↗ |
| 8 | INCY Incyte Corporation | 30,177 | $3.7M | 0.8% | +2.1% | 13F ↗ |
| 9 | BMRN BioMarin Pharmaceutical Inc. | 60,783 | $3.6M | 0.8% | +192% | 13F ↗ |
| 10 | VSTM Verastem, Inc. | 411,097 | $3.3M | 0.7% | +44.9% | 13F ↗ |
| 11 | PGEN Precigen, Inc. | 378,763 | $3.2M | 0.7% | +44.9% | 13F ↗ |
| 12 | OKTA Okta, Inc. | 13,971 | $2.9M | 0.6% | New | 13F ↗ |
| 13 | MRVL Marvell Technology, Inc. | 10,907 | $2.9M | 0.6% | -4.3% | 13F ↗ |
| 14 | HALO Halozyme Therapeutics, Inc. | 24,252 | $2.7M | 0.6% | +44.9% | 13F ↗ |
| 15 | HPE Hewlett Packard Enterprise Company | 41,739 | $2.7M | 0.6% | New | 13F ↗ |
| 16 | ZLAB Zai Lab Limited · ADR | 98,741 | $2.6M | 0.6% | +44.9% | 13F ↗ |
| 17 | AMD Advanced Micro Devices, Inc. | 4,186 | $2.6M | 0.6% | -22.3% | 13F ↗ |
| 18 | RIGL Rigel Pharmaceuticals, Inc. | 51,309 | $2.5M | 0.5% | +44.9% | 13F ↗ |
| 19 | MU Micron Technology, Inc. | 2,319 | $2.5M | 0.5% | -32.5% | 13F ↗ |
| 20 | KNSA Kiniksa Pharmaceuticals International, plc | 32,483 | $2.4M | 0.5% | +44.9% | 13F ↗ |
| 21 | NEM Newmont Corporation | 20,793 | $2.4M | 0.5% | +33.9% | 13F ↗ |
| 22 | XERS Xeris Biopharma Holdings, Inc. | 248,233 | $2.4M | 0.5% | +44.9% | 13F ↗ |
| 23 | PANW Palo Alto Networks, Inc. | 5,965 | $2.4M | 0.5% | New | 13F ↗ |
| 24 | STX Seagate Technology Holdings PLC | 2,547 | $2.3M | 0.5% | New | 13F ↗ |
| 25 | A Agilent Technologies, Inc. | 13,540 | $2.3M | 0.5% | -13.1% | 13F ↗ |
| 26 | ONC BeOne Medicines Ltd. · ADR | 6,373 | $2.3M | 0.5% | +44.9% | 13F ↗ |
| 27 | GLW Corning Incorporated | 15,101 | $2.3M | 0.5% | +40.8% | 13F ↗ |
| 28 | LRCX Lam Research Corporation | 7,059 | $2.3M | 0.5% | +1.7% | 13F ↗ |
| 29 | NTAP NetApp, Inc. | 10,903 | $2.3M | 0.5% | -34.4% | 13F ↗ |
| 30 | ANET Arista Networks, Inc. | 11,213 | $2.3M | 0.5% | +7.3% | 13F ↗ |
| 31 | KEYS Keysight Technologies Inc. | 6,236 | $2.3M | 0.5% | +17.9% | 13F ↗ |
| 32 | FTNT Fortinet, Inc. | 12,688 | $2.3M | 0.5% | New | 13F ↗ |
| 33 | IBRX ImmunityBio, Inc. | 237,394 | $2.2M | 0.5% | +44.9% | 13F ↗ |
| 34 | APH Amphenol Corporation | 26,458 | $2.2M | 0.5% | +9.1% | 13F ↗ |
| 35 | NVDA NVIDIA Corporation | 9,659 | $2.2M | 0.5% | +16.1% | 13F ↗ |
| 36 | WAT Waters Corporation | 4,957 | $2.2M | 0.5% | New | 13F ↗ |
| 37 | PTGX Protagonist Therapeutics, Inc. | 15,354 | $2.2M | 0.5% | +44.9% | 13F ↗ |
| 38 | GRMN Garmin Ltd. | 7,503 | $2.2M | 0.5% | +7.1% | 13F ↗ |
| 39 | QCOM QUALCOMM Incorporated | 11,684 | $2.2M | 0.5% | New | 13F ↗ |
| 40 | TARS Tarsus Pharmaceuticals, Inc. | 27,207 | $2.1M | 0.5% | +44.9% | 13F ↗ |
| 41 | ETN Eaton Corporation, PLC | 4,926 | $2.1M | 0.5% | +13.9% | 13F ↗ |
| 42 | WST West Pharmaceutical Services, Inc. | 5,646 | $2.1M | 0.5% | -5.3% | 13F ↗ |
| 43 | COP ConocoPhillips | 16,678 | $2.1M | 0.5% | New | 13F ↗ |
| 44 | PWR Quanta Services, Inc. | 3,234 | $2.1M | 0.5% | +14.4% | 13F ↗ |
| 45 | DDOG Datadog, Inc. | 7,586 | $2.1M | 0.5% | -44.2% | 13F ↗ |
| 46 | FOXA Fox Corporation Class A | 32,969 | $2.1M | 0.5% | +16.8% | 13F ↗ |
| 47 | ADI Analog Devices, Inc. | 5,201 | $2.1M | 0.5% | New | 13F ↗ |
| 48 | LGND Ligand Pharmaceuticals Incorporated | 6,595 | $2.1M | 0.5% | +44.9% | 13F ↗ |
| 49 | ADMA ADMA Biologics Inc | 205,298 | $2.1M | 0.5% | +44.9% | 13F ↗ |
| 50 | AMZN Amazon.com, Inc. | 8,243 | $2.1M | 0.5% | +19.4% | 13F ↗ |
Showing the top 50 of 458 positions. Premium lists every position, plus puts and calls.
Changes since Q2 2026
45 new, 186 added to, 227 trimmed, 50 exited, 0 unchanged. By estimated dollars.
New positions (45)
| OKTA Okta, Inc. | 13,971 | New | $2.9M |
| HPE Hewlett Packard Enterprise Company | 41,739 | New | $2.7M |
| PANW Palo Alto Networks, Inc. | 5,965 | New | $2.4M |
| STX Seagate Technology Holdings PLC | 2,547 | New | $2.3M |
| FTNT Fortinet, Inc. | 12,688 | New | $2.3M |
| WAT Waters Corporation | 4,957 | New | $2.2M |
| QCOM QUALCOMM Incorporated | 11,684 | New | $2.2M |
| COP ConocoPhillips | 16,678 | New | $2.1M |
| ADI Analog Devices, Inc. | 5,201 | New | $2.1M |
| LNG Cheniere Energy, Inc. | 7,546 | New | $2.0M |
Added to (186)
| VRTX Vertex Pharmaceuticals Incorporated | 7,668 | +193% | $2.6M |
| BMRN BioMarin Pharmaceutical Inc. | 60,783 | +192% | $2.4M |
| MRNA Moderna, Inc. | 33,770 | +44.9% | $2.0M |
| IOVA Iovance Biotherapeutics, Inc. | 413,111 | +44.9% | $1.9M |
| WMB Williams Companies, Inc. | 29,934 | +1049% | $1.9M |
| WEC WEC Energy Group, Inc. | 18,689 | +982% | $1.7M |
| OMER Omeros Corporation | 192,959 | +44.9% | $1.1M |
| VSTM Verastem, Inc. | 411,097 | +44.9% | $1.0M |
| PGEN Precigen, Inc. | 378,763 | +44.9% | $1.0M |
| REGN Regeneron Pharmaceuticals, Inc. | 5,490 | +27.1% | $887.2K |
Trimmed (227)
| DDOG Datadog, Inc. | 7,586 | -44.2% | -$1.6M |
| DVN Devon Energy Corporation | 44,607 | -40.4% | -$1.4M |
| EIX Edison International | 3,624 | -87.5% | -$1.4M |
| NTAP NetApp, Inc. | 10,903 | -34.4% | -$1.2M |
| MU Micron Technology, Inc. | 2,319 | -32.5% | -$1.2M |
| ALNY Alnylam Pharmaceuticals, Inc. | 5,959 | -40.1% | -$985.5K |
| AMD Advanced Micro Devices, Inc. | 4,186 | -22.3% | -$733.5K |
| LLY Eli Lilly and Company | 1,559 | -24.8% | -$595.9K |
| RWAY Runway Growth Finance Corp. | 42,464 | -64.9% | -$520.1K |
| UAL United Airlines Holdings, Inc. | 15,376 | -21.6% | -$470.0K |
Exited (50)
| ILMN Illumina, Inc. | 14,025 | Exited | -$2.5M |
| CAT Caterpillar, Inc. | 2,173 | Exited | -$2.3M |
| RCL Royal Caribbean Cruises Ltd. | 6,961 | Exited | -$2.2M |
| HOOD Robinhood Markets, Inc. | 21,467 | Exited | -$2.2M |
| URI United Rentals, Inc. | 1,877 | Exited | -$2.1M |
| MRK Merck & Company, Inc. | 16,352 | Exited | -$2.1M |
| MET MetLife, Inc. | 23,205 | Exited | -$2.0M |
| PFG Principal Financial Group Inc | 18,072 | Exited | -$1.9M |
| FAST Fastenal Company | 39,803 | Exited | -$1.9M |
| EXPE Expedia Group, Inc. | 7,351 | Exited | -$1.9M |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Every position, puts and calls. Part of Premium.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Any two quarters side by side. Part of Premium.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 12, 2026 | 13F-HR | 458 | $452.8M | Current | SEC ↗ |
| Q2 2026 | Aug 11, 2026 | 13F-HR | 463 | $429.2M | Current | SEC ↗ |
| Q1 2026 | May 14, 2026 | 13F-HR | 450 | $362.5M | Current | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | 13F-HR | 461 | $367.9M | Current | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | 13F-HR | 440 | $349.3M | Current | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | 13F-HR | 439 | $295.8M | Current | SEC ↗ |
| Q1 2025 | May 15, 2025 | 13F-HR | 473 | $367.8M | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer